Search results
Results from the WOW.Com Content Network
Patients who have experienced an acute renal infarction usually report sudden onset flank pain, which is often accompanied by fever, nausea, and vomiting. [ 4 ] The primary causes of renal infarction are hypercoagulable conditions, renal artery damage (usually brought on by arterial dissection ), and cardioembolic illness.
Improvement slows thereafter and some deficits may be permanent. There is controversy over whether small subsegmental PEs need treatment at all [102] and some evidence exists that patients with subsegmental PEs may do well without treatment. [64] [103] Once anticoagulation is stopped, the risk of a fatal pulmonary embolism is 0.5% per year. [104]
Kidney ischemia [1] is a disease with a high morbidity and mortality rate. [2] Blood vessels shrink and undergo apoptosis which results in poor blood flow in the kidneys. More complications happen when failure of the kidney functions result in toxicity in various parts of the body which may cause septic shock, hypovolemia, and a need for surgery. [3]
Additionally, patients with aHUS typically present with an abrupt onset of systemic signs and symptoms such as acute kidney failure, [15] hypertension (high blood pressure), [19] myocardial infarction (heart attack), [23] stroke, [14] lung complications, [23] pancreatitis (inflammation of the pancreas), [21] liver necrosis (death of liver cells ...
It is regarded as a highly sensitive and specific test for pulmonary embolism. [1] CTPA is typically only requested if pulmonary embolism is suspected clinically. If the probability of PE is considered low, a blood test called D-dimer may be requested. If this is negative and risk of a PE is considered negligible, then CTPA or other scans are ...
Wells score for PE [3] Variable Points Clinical signs and symptoms of DVT 3 An alternate diagnosis is less likely than PE 3 Heart rate >100 1.5 Immobilization or surgery in the previous 4 weeks 1.5 Previous DVT / PE 1.5 Hemoptysis 1 Malignancy (treatment currently, in the previous 6 months, or palliative) 1
Assuming a normal circulation, an embolus formed in a systemic vein will always impact in the lungs, after passing through the right side of the heart. This will form a pulmonary embolism that will result in a blockage of the main artery of the lung and can be a complication of deep-vein thrombosis.
Alteplase, sold under the brand name Activase among others, is a biosynthetic form of human tissue-type plasminogen activator (t-PA). It is a thrombolytic medication used to treat acute ischemic stroke, acute ST-elevation myocardial infarction (a type of heart attack), pulmonary embolism associated with low blood pressure, and blocked central venous catheter. [5]